Posts

Posted on

KMX INVESTOR LOSSES: CarMax, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 2 to Protect Your Rights

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

Investors have until January 2, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in CarMax securities. The case is pending in the U.S. District Court for the District of Maryland and is captioned Jason Cap v. CarMax, Inc., et al., No. 1:25-cv-03602.

Why is CarMax Being Sued For Securities Fraud?

CarMax sells used cars. During the relevant period, the Company touted the strong and sustainable demand for its cars, driven by factors such as a seamless customer experience.

As alleged, in truth, it appears that the announcement of U.S. tariffs imposed on cars provided a short-term boost to demand, as customers purchased cars prior to the tariffs taking effect.

BFA Law is also investigating the unexpected departure of CEO Bill Nash on November 6, 2025, and whether CarMax properly assessed or reserved for its portfolio of car loans.

Why did CarMax’s Stock Drop?

On September 25, 2025, the Company reported disappointing financial results for the second quarter of its fiscal year 2026. Specifically, CarMax announced sales declines across the board, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units. The Company also posted a disappointing second quarter net income of about $95.4 million, down from $132.8 million over the prior year. A main reason for the declines, according to CarMax, was a “pull forward” in demand into the first fiscal quarter due to the announcement of tariffs.

On this news, the price of CarMax stock dropped $11.45 per share, or roughly 20%, from $57.05 per share on September 24, 2025, to $45.60 per share on September 25, 2025.

Then, on November 6, 2025, CarMax announced the unexpected departure of CEO Bill Nash and a weak preliminary Q3 2025 outlook. On this news, the price of CarMax stock dropped over 24%.

Click here for more information:

https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit

.

What Can You Do?

If you invested in CarMax you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

GAUZ Investors Have Opportunity to Lead Gauzy Ltd. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Dec. 25, 2025 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline.

So what: If you purchased Gauzy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Gauzy class action, go to https://rosenlegal.com/submit-form/?case_id=48715 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 6, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the Case: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) three of Gauzy’s French subsidiaries lacked the financial means to meet their debts as they became due; (2) as a result, it was substantially likely insolvency proceedings would be commenced; (3) as a result, it was substantially likely a potential default under Gauzy’s existing senior secured debt facilities would be triggered; and (4) as a result of the foregoing, defendants’ positive statements about Gauzy’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Gauzy class action, go to https://rosenlegal.com/submit-form/?case_id=48715 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/gauz-investors-have-opportunity-to-lead-gauzy-ltd-securities-fraud-lawsuit-302649356.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Dec. 25, 2025 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.

So what: If you purchased Skye securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Skye Bioscience, Inc. class action, go to https://rosenlegal.com/submit-form/?case_id=48064 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements regarding Skye’s business, operations, and prospects. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) nimacimab was less effective than defendants had led investors to believe; (2) accordingly, nimacimab’s clinical, regulatory, and commercial prospects were overstated; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Skye Bioscience class action, go to https://rosenlegal.com/submit-form/?case_id=48064 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/skye-investors-have-opportunity-to-lead-skye-bioscience-inc-securities-fraud-lawsuit-302649382.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

ITGR INVESTOR LOSSES: Integer Holdings Corporation Investors May have been Affected by Fraud – Contact BFA Law by February 9 to Protect Your Rights

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.

Investors have until February 9, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Integer common stock. The case is pending in the U.S. District Court for the Southern District of New York and is captioned West Palm Beach Firefighters’ Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251.

Why is Integer Being Sued For Securities Fraud?

Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology (“EP”) devices that map the heart’s electrical activity to diagnose and treat arrhythmias.

During the relevant period, Integer repeatedly touted its EP sales growth and market position while overstating demand for its EP devices.

As alleged, in truth, demand for and revenue from Integer’s EP products had fallen sharply—directly contradicting the Company’s public assurances.

Why did Ineger’s Stock Drop?

On October 23, 2025, Integer disclosed that it lowered its 2025 sales guidance to a range between $1.840 billion and $1.854 billion, from a range between $1.850 billion and $1.876 billion, and well below analysts’ estimates. The Company also revealed that it expected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. Integer also admitted that two of its EP devices experienced “slower than forecasted” adoption and that it expected the slower demand “to continue into 2026.” This news caused the price of Integer stock to drop $35.22 per share, or more than 32%, from a closing price of $109.11 per share on October 22, 2025, to $73.89 per share on October 23, 2025.

Click here for more information:

https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit

.

What Can You Do?

If you invested in Integer, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

INSP INVESTOR LOSSES: Inspire Medical Systems, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 5 to Protect Your Rights

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

Investors have until January 5, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Inspire stock. The case is pending in the U.S. District Court for the District of Minnesota and is captioned City of Pontiac Reestablished General Employees’ Retirement System v. Inspire Medical Systems, Inc., et al., No. 0:25-cv-04247.

Why is Inspire Being Sued For Securities Fraud?

Inspire develops and manufactures an implantable medical device for the treatment of sleep apnea. The latest version of the device is the Inspire V. The company announced FDA approval of Inspire V on August 2, 2024.

During the relevant period, Inspire repeatedly assured investors that it had taken all necessary steps to facilitate the launch of Inspire V and that it would launch the device as soon as sufficient inventory was available to meet supposedly high demand.

As alleged, in truth, Inspire failed to take basic steps to prepare clinicians and payors for the rollout, resulting in significant delays in adoption of the device. Moreover, the launch suffered from weak demand, as many customers already had excess inventory of the company’s older devices.

Why did Inspire’s Stock Drop?

On August 4, 2025, Inspire disclosed that the Inspire V launch was facing an “elongated timeframe” and as a result, it was reducing its 2025 earnings per share guidance by more than 80%. The company attributed the longer timeframe to a number of previously undisclosed factors including that many implanting centers “did not complete the training, contracting and onboarding required prior to the purchase and implant of Inspire V,” that certain “software updates for claims submissions and processing did not take effect until July 1, [2025]” which meant implanting centers could not bill for procedures until that date, and that demand for the Inspire V was poor because Inspire’s customers had a backlog of older versions of the company’s device.

On this news, the price of Inspire stock dropped $42.04 per share, or more than 32%, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025.

Click here for more information:

https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit

.

What Can You Do?

If you invested in Inspire you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

ARE INVESTOR LOSSES: Alexandria Real Estate Equities, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 26 to Protect Your Rights

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.

Investors have until January 26, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities. The case is pending in the U.S. District Court for the Central District of California and is captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv- 11319.

Why is Alexandria Real Estate Being Sued For Securities Fraud?

Alexandria Real Estate is a real estate investment trust. Its tenants are concentrated in life science industries, such as pharmaceutical and biotechnology companies.

During the relevant period, Alexandria Real Estate touted its leasing volume and development pipeline, specifically regarding a property in Long Island City, New York, stating that leasing volume was “solid” and its pipeline was “well positioned to capture future demand when expansion needs arise.”

As alleged, in truth, Alexandria Real Estate was experiencing lower occupancy rates and slower leasing activity such that it was required to take a real estate impairment charge of $323.9 million with $206 million attributed to its Long Island City property.

Why did Alexandria Real Estate’s Stock Drop?

On October 27, 2025, Alexandria Real Estate announced results below expectations for 3Q 2025 and cut guidance for the remainder of the fiscal year. The company attributed the results to lower occupancy rates and slower leasing activity. It also announced a real estate impairment charge of $323.9 million with $206 million attributed to its Long Island City property, stating that the property was not a life science destination that could scale. Alexandria Real Estate also announced additional impairment charges that may be recognized in 4Q 25 ranging from $0 to $685 million. This news caused the price of Alexandria Real Estate stock to drop $14.93 per share, or more than 19%, from a closing price of $77.87 per share on October 27, 2025, to $62.94 per share on October 28, 2025.

Click here for more information:

https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit

.

What Can You Do?

If you invested in Alexandria Real Estate you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

PR Newswire

TOKYO, Dec. 25, 2025 /PRNewswire/ — Leifras Co., Ltd. (NASDAQ: LFS, Head Office: Shibuya-ku, Tokyo, Representative Director: Kiyotaka Ito, hereinafter referred to as “the Company”), which operates sports schools for children and supports the local expansion of club activities, is pleased to announce that it has entered into a commitment line agreement (hereinafter referred to as “this Agreement”) totaling 2.5 billion yen with Chikuho Bank, Ltd. (hereinafter referred to as “Chikuho Bank”) and Mizuho Bank, Ltd. (hereinafter referred to as “Mizuho Bank”) as arrangers and agents, respectively.

Purpose of this Agreement

Having listed on the NASDAQ market in the United States in October 2025, the Company will accelerate its global business expansion under its corporate philosophy of ” Changing and Designing Sports.”

This agreement was concluded with the aim of securing flexible financing methods and further strengthening the company’s financial base.

The establishment of a commitment line totaling 2.5 billion yen from multiple financial institutions, with Chikuho Bank, a leading regional bank in Kyushu, and Mizuho Bank, a megabank, as arrangers, serves as a testament to the high evaluation of our business foundation and financial soundness.

Commitment Line Overview 

1. Chikuho Bank Arrangement Project
Contract signing date: October 31, 2025
Arrangement amount: 1 billion yen
Arranger and agent: Chikuho Bank Ltd.
Lenders: Chikuho Bank, Ltd., SBI Shinsei Bank, Ltd.
Use of funds: Working capital

2. Mizuho Bank Arrangement Project
Contract signing date: November 19, 2025
Arrangement amount: 1.5 billion yen
Arranger and agent: Mizuho Bank, Ltd.
Lenders: Mizuho Bank, Ltd., Saga Bank, Ltd., Fukuoka Bank, Ltd., Resona Bank, Ltd.
Use of funds: Working capital

Future Plans

We will focus on expanding our school and social businesses. Furthermore, research into children’s non-cognitive abilities is actively progressing in Europe and the United States, and non-cognitive abilities are gaining more attention each year. In light of this situation, we are expanding our methods for developing children’s non-cognitive abilities, which we established in Japan, to overseas markets. By acquiring overseas children’s sports schools, we will promote the development of sports services globally and contribute to the development of non-cognitive abilities in children around the world.

Lei
fras Company Profile

Leifras Co., Ltd. is a social business company that sees its mission as resolving social issues through sports, based on its corporate philosophy of “Changing and designing sports.”

The number of members in our children’s sports school business has reached approximately 70,000, and we will continue to work hard to contribute to society through the sports business through club activity support, healthcare, and community collaboration projects.

Company name                 : Leifras Co., Ltd.
Listing market      : Nasdaq Capital Market
Ticker (US stock code): LFS
Headquarters                     : Ebisu Garden Place Tower 20th floor, 4-20-3 Ebisu, Shibuya-ku, Tokyo
Date of establishment        : August 28, 2001
Representative     : Representative Director Kiyotaka Ito
Capital                 : 784,666,480 yen (including capital reserve)
Business details    : Sports school business, event business, alliance business
                            Club activity support projects Community collaboration projects Healthcare projects
                            After-school day care service “LEIF” business
Website               : https://www.leifras.co.jp/
IR website            : https://ir.leifras.co.jp/jp/ 

 

Cision View original content:https://www.prnewswire.com/news-releases/leifras-notice-regarding-the-conclusion-of-a-commitment-line-agreement-totaling-2-5-billion-yen-to-diversify-fund-raising-channels-and-strengthen-the-financial-base-302649462.html

SOURCE Leifras Co.,Ltd

Posted on

SNPS INVESTOR LOSSES: Synopsys, Inc. Investors May have been Affected by Fraud – Contact BFA Law by December 30 to Protect Your Rights

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

Investors have until December 30, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Synopsys securities. The class action is pending in the U.S. District Court for the Northern District of California and is captioned Kim v. Synopsys, Inc., et al., No. 3:25-cv-09410.

Why Was Synopsys Sued for Securities Fraud?

Synopsys provides design automation software products used to design and test integrated circuits. The Company’s Design IP segment, which provides pre-designed silicon components to semiconductor companies, has been the Company’s fastest-growing segment, growing from 25% of its revenue in 2022, to 31% in 2024.

During the relevant period, Synopsys told investors that its customers “rely on Synopsys IP to minimize integration risk and speed time to market” and that it was seeing “strength in Europe and South Korea.” Synopsys also stated it was “continuing to develop and deploy[] AI into our products and the operations of our business.”

As alleged, in truth, the Company’s Design IP customers began to require additional customization for IP components, which was deteriorating the economics of its Design IP business and jeopardizing its business model.

The Stock Declines as the Truth Is Revealed

On September 9, 2025, Synopsys released its Q3 2025 financial results, revealing its “IP business underperformed expectations.” The Company reported revenue for its Design IP segment of $425.9 million, a 7.7% decline year-over-year and net income of $242.5 million, a 43% year-over-year decline. The Company revealed that its Design IP customers require “more and more customization,” which “takes longer” and requires “more resources.” As a result, the Company stated it was having “an ongoing dialogue with our customers” regarding changing its business model. This news caused the price of Synopsys stock to fall $217.59 per share, or nearly 36%, from $604.37 per share on September 9, 2025, to $387.78 per share on September 10, 2025.

Click here for more information:

https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit

.

What Can You Do?

If you invested in Synopsys you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

LRN INVESTOR LOSSES: Stride, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 12 to Protect Your Rights

NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

Investors have until January 12, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Stride securities. The case is pending in the U.S. District Court for the Eastern District of Virginia and is captioned MacMahon v. Stride, Inc., et al., No. 1:25-cv- 02019.

Why is Stride Being Sued For Securities Fraud?

Stride is an education technology company that provides an online platform to students throughout the U.S. During the relevant period, Stride stated it was seeing “increasing growth in our business,” “in-year strength in demand” for its products and services, and that its customers and potential customers “continue to choose us in record numbers.”

As alleged, in truth, Stride had inflated enrollment numbers by retaining “ghost students,” ignored compliance requirements for its employees, and had “poor customer experience” that resulted in “higher withdrawal rates,” “lower conversion rates,” and had driven students away.

Why did Stride’s Stock Drop?

On September 14, 2025, a report stated that a complaint had been filed against Stride for fraud, deceptive trade practices, systemic violations of law, and intentional and tortious misconduct. It claimed Stride inflated enrollment numbers by retaining “ghost students” on rolls to secure state funding and ignored compliance requirements, including background checks and licensure laws for its employees. This news caused the price of Stride stock to drop $18.60 per share, or more than 11%, from a closing price of $158.36 per share on September 12, 2025, to $139.76 per share on September 15, 2025.

Then, on October 28, 2025, Stride admitted that “poor customer experience” resulted in “higher withdrawal rates,” “lower conversion rates,” and drove students away. Stride estimated the impact caused approximately 10,000-15,000 fewer enrollments and stated that, because of this, its outlook is “muted” compared to prior years. This news caused the price of Stride stock to drop $83.48 per share, or more than 54%, from a closing price of $153.53 per share on October 28, 2025, to $70.05 per share on October 29, 2025.

Click here for more information:

https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

.

What Can You Do?

If you invested in Stride you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

Tuya Smart Launches “Hey Tuya:” A Super AI Life Assistant Bringing Physical AI to Everyday Life

PR Newswire


  • Is the real-life J.A.R.V.I.S AI assistant from Marvel’s Iron Man movies almost here?

HANGZHOU, China, Dec. 25, 2025 /PRNewswire/ — Tuya Smart (NYSE: TUYA; HKEX: 2391), a global AI cloud platform service provider, today announced the launch of Hey Tuya, a next-generation Super AI Life Assistant designed to seamlessly integrate artificial intelligence into daily life. Hey Tuya marks a major milestone in the evolution of AI agents and physical AI. Built on a multi-agent collaborative architecture, it will transform how AI moves beyond screens to deliver proactive, intelligent assistance across home, office, and more scenarios in daily life.

Multi-Device Collaboration: Making AI Ubiquitous

Much like J.A.R.V.I.S., Tony Stark’s iconic AI assistant in the Iron Man movies, Hey Tuya is evolving into more than a virtual assistant answering simple questions. It is designed to become an AI life assistant capable of sensing environments, learning user habits, and coordinating with physical devices. Unlike traditional AI assistants confined to single devices, Hey Tuya is engineered to break beyond the screen, empowering users to summon their AI assistant from anywhere, whether through the Tuya App, smart speakers, control hubs, or even AI toys and wearables. It will facilitate multi-device collaboration and orchestrate smart devices and equipment, delivering a connected and intelligent experience throughout everyday life.

Hey Tuya will feature short-term and long-term memory, designed to learn and adapt to users’ routines, environmental preferences, and habits. Over time, it will evolve beyond reactive commands to anticipate needs and offer proactive recommendations. As it learns your habits, Hey Tuya will possibly suggest turning on the air conditioner 30 minutes before you arrive home, preheating the water heater and opening bedroom curtains ahead of your 7 a.m. wake-up, or dimming lights and activating a humidifier as you wind down for sleep. This continuous learning process will make interactions feel more intuitive, seamless, and efficient.

Full-Scenario Coverage: From Home to Office and Beyond

Hey Tuya’s capabilities are designed to span diverse life scenarios, taking on different roles:

  • Home Security Guardian: Will provide round-the-clock security, with image recognition and retrieval, converting results into easy-to-understand voice or text alerts for clear safety status.
  • Energy-Saving Expert: Will monitor and analyze energy consumption in real time, proactively suggesting strategies like turning off idle devices, shutting off appliances during weekend trips, or adjusting AC temperatures according to weather and seasonal changes, making it easy to save energy with minimal effort.
  • Health Coach: Will focus on physical and mental well-being, support calorie recognition, track sleep and exercise data, and generate personalized health reports.
  • Efficient Work Assistant: Will offer meeting minutes generation, real-time multilingual translation, content summarization, and mind mapping to boost productivity.
  • Personal Life Secretary: Will manage daily tasks such as reminders, holiday alerts, pet and plant care, and family health monitoring for an organized life.

Powered by Tuya’s Proprietary PAE Technology

Hey Tuya’s ubiquitous AI experience is built on Tuya’s proprietary PAE (Physical AI Engine), which deploys the AI-Device Real-Time Network (AD-RTN) edge acceleration network globally. With the AD-RTN as a foundation, Tuya Real-Time Communication (T-RTC) provides a reliable, low-latency, resilient, and global real-time communication system for AI devices.

Tuya has further developed engines for natural language multimodal interaction (Conversational AI Engine), visual understanding (Vision AI Engine), and IoT device communication and control (IoT Intelligence Engine). Leveraging OmniMem long-term memory technology, PAE enables continuous learning across multimodal interactions and device behaviors, allowing the AI to truly understand user preferences and spatial habits.

Through its Adaptive Expert System (AES) and Dynamic Orchestration Agent (DOA), PAE deeply integrates AI cognition and decision-making with real-world smart devices, forming a complete loop from perception to execution—creating intelligent spaces that grow and self-optimize.

Hey Tuya will be available to individual consumers and open to global brands and developers, who will be able to integrate Hey Tuya into their AI hardware or customize it further. Tuya’s open DNA will accelerate the evolution and adoption of Physical AI worldwide, fostering an open, symbiotic, and vibrant AIoT ecosystem.

Currently, developers have created over 12,000 AI Agents on Tuya’s platform, with 155 million daily AI interactions globally across various scenarios. In the future, Hey Tuya will integrate user feedback and best practices to further enhance the experience.

Availability

Hey Tuya is now live with initial capabilities. Users can download the Tuya App from major app stores or visit Tuya.AI to begin the journey with Hey Tuya as it continues to expand its full range of features.

About Tuya Smart

Tuya Smart (NYSE: TUYA; HKEX: 2391) is a global leader in AI cloud platform services, dedicated to applying AI to everyday life. Through its AI Agent development platform and TuyaOpen open-source framework, Tuya integrates multimodal AI capabilities, lowers development barriers, and accelerates AI’s integration with the physical world. Tuya provides innovative Physical AI solutions for smart devices, commercial applications, and industry developers, fostering an open and neutral global ecosystem. As of September 30, 2025, Tuya’s AI developer platform has over 1.622 million registered accounts across more than 200 countries and regions.

For more information: About Tuya | Tuya Smart 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tuya-smart-launches-hey-tuya-a-super-ai-life-assistant-bringing-physical-ai-to-everyday-life-302649448.html

SOURCE Tuya Smart